(US) /    Tel: (781) 999-4286 / (781) 999-5354
Home > PDGFR
Cat.No. Product Name Information Area
T5109 Avapritinib Avapritinib is a dual inhibitor of the mutant KIT receptor (KIT D816V, IC50: 0.27 nM)...
T3476 JI-101 JI-101 is an oral multi-kinase inhibitor that targets vascular endothelial growth fac... Cardiovascular
T6930 Pazopanib HCl Pazopanib HCl (GW786034 HCl) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEG... Others
T2288 Motesanib Motesanib is an orally bioavailable receptor tyrosine kinase inhibitor with potential... Cancer
T6711 Tyrphostin AG 1296 Tyrphostin AG 1296 is an inhibitor of PDGFR with IC50 of 0.3-0.5 μM, no activity to E... Cancer
T6230 Imatinib matinib is an inhibitor of the receptor tyrosine kinases c-Abl, Bcr-Abl, PDGFR, and c... Cancer
T6124 Mubritinibnew Mubritinib (TAK-165) is a potent inhibitor of HER2/ErbB2 with IC50 of 6 nM. Cancer
T6091 CP-673451 CP-673451 is a specific inhibitor of PDGFRα/β (IC50: 10/1 nM) with antiangiogenic and... Cancer
T3072 XL019 XL019 is a potent and selective JAK2 inhibitor with IC50 of 2.2 nM, 100 fold selectiv... Cancer
T2734 Sennoside B Sennoside B is an anthranoid. Anthranoid derivatives are used all over the world as a... Cancer
T2677 Crenolanib Crenolanib is an orally bioavailable type III tyrosine kinases inhibitor of PDGFRα/β ... Cancer
T2624 OSI 930 OSI-930, an orally active inhibitor of c-Kit and the vascular endothelial growth fact... Cancer
T2609 Masitinib Masitinib is a tyrosine-kinase inhibitor used in the treatment of mast cell tumors in... Cancer
T2516 Amuvatinib Amuvatinib is an orally bioavailable synthetic carbothioamide with potential antineop... Cancer
T2514 Linifanib Linifanib (ABT-869) is a novel, potent ATP-competitive VEGFR/PDGFR inhibitor for KDR ... Cancer
T2500 Cediranib Cediranib (AZD2171) is a highly potent (IC50 < 1 nmol/L) ATP-competitive inhibitor of... Cancer
T2479 Tyrphostin 9 Tyrphostin 9 is an Agricultural acaricide, now superseded. Tyrphostin 9 is firstly de... Cancer
T2446 KI8751 KI8751 is a potent and selective inhibitor of VEGFR2 with IC50 of 0.9 nM. Cancer
T2415 PP121 PP-121 is a multi-targeted inhibitor of PDGFR (IC50: 2 nM), Hck (IC50: 8 nM), mTOR (I... Cancer
T2372 Ponatinib Ponatinib is an orally available, multitargeted kinase inhibitor (IC50s: 0.37/1.1/1.5... Cardiovascular System
T2288L Motesanib Diphosphate Motesanib Diphosphate is the orally bioavailable diphosphate salt of a multiple-recep... Cancer
T2070 CEP-32496 CEP-32496 is a highly potent inhibitor of BRAF. Other
T2047 AG-1478 AG-1478 (Tyrphostin AG-1478) is a selective EGFR inhibitor. Cancer
T1895 SKLB 610 SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kin... Cancer
T1836 AZD2932 AZD2932 is a potent and multi-targeted kinase inhibitor VEGFR2, PDGFβ, Flt-3, and c-K... Other
T1792 Regorafenib Regorafenib (BAY 73-4506) is a multi-targeted receptor tyrosine kinase inhibitor (IC5... Cancer
T1785 Palbociclib Palbociclib is an orally available cyclin-dependent kinase (CDK) inhibitor with poten... Cancer
T1777 Nintedanib Nintedanib is an inhibitor of the receptor tyrosine kinases VEGFR/FGFR/PDGFR (IC50s: ... Other
T1667 Tandutinib Tandutinib (MLN518, CT53518), an effective FLT3 antagonist (IC50: 0.22 μM), can also ... Cancer
T1621 Imatinib Mesylate Imatinib mesylate is a tyrosine kinase receptor inhibitor with antineoplastic activit... Cancer